F33 F32
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Primary Diagnosis of MDD according to DSM-IV (SCID-I-Interview) severity of depression > 16 Punkte in HRSD-Interview. willingness to participate in the study (informed consent) willingness to participate over a maximum of 6 months in the study and take part in the therapy session regularly (no plans to move or to have inpatient treatment)
Exclusion criteria
Exclusion criteria: lifetime diagnosis of psychotic disorder lifetime diagnosis of bipolar disorder IQ below 85 acute sucidality acute serious substance abuse disorder, that calls for detoxication Inadequate german language skills
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| primary outcome: severity of depressive symptoms assessed by the Hamilton Rating Scale for Depression (HRSD) at the end of treatment (6 months assessment) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes address general psychopathology (BSI), quality of life (SF-12), psychosocial functioning and participation (WHODAS), course of other psychiatric disorders (SKID I und II), metacognitions, rumination and worying (MDD-S, MCQ-30, RSQ-D) as well as behavioral activation (BADS).Secondary Outcomes will be assessed at baseline as well as 3, 6, 12, 18 and 30months after start of treatment | — |
Countries
Germany
Contacts
Klinik für Psychiatrie und Psychotherapie, Universität zu Lübeck